Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps

A Global Antimicrobial Conservation Fund for Low- and Middle-Income Countries

(2016) Marc Mendelson et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach

(2016) John H Rex et al.   LANCET INFECTIOUS DISEASES

Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis

(2016) Ruth Kelly et al.   LANCET INFECTIOUS DISEASES

Accelerating global innovation to address antibacterial resistance: introducing CARB-X

(2016) Kevin Outterson et al.   NATURE REVIEWS DRUG DISCOVERY

A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility

(2016) David M. Brogan et al.   Globalization and Health

Strategies for achieving global collective action on antimicrobial resistance

(2015) Steven J Hoffman et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Repairing The Broken Market For Antibiotic Innovation

(2015) Kevin Outterson et al.   HEALTH AFFAIRS

A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics

(2015) Matthew J Renwick et al.   JOURNAL OF ANTIBIOTICS

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistance

(2015) T. Kostyanev et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Innovative Medicines Initiative and antibiotic resistance

(2015) Tomislav Kostyanev et al.   LANCET INFECTIOUS DISEASES

Antibiotics in the clinical pipeline in 2013

(2013) Mark S Butler et al.   JOURNAL OF ANTIBIOTICS

A comprehensive regulatory framework to address the unmet need for new antibacterial treatments

(2013) John H Rex et al.   LANCET INFECTIOUS DISEASES

Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model

(2013) David M Brogan et al.   Globalization and Health

Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement

(2008) Ian Chopra et al.   LANCET INFECTIOUS DISEASES